1 completed, 1 recruiting, 1 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Cardioversion: new trials by email Literature Review of Cardioversion trials Research Report on Cardioversion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MAX - SHOCK Clinical Trial biphasic defibrillator with maximum energy of 200J (® Zoll), biphasic defibrillator with maximum energy of 360J (® Physio-Control) - Cardioversion, Atrial Fibrillation | Not applicable | Recruiting | Ottawa Heart Institute Research Corporation | 376 | 2025-03-31 | 2026-02-03 |
| Heart Watch Study: a Pragmatic Randomized Controlled Trial Apple Watch, Withings Move - Cardioversion, Atrial Fibrillation | Not applicable | Completed | Yale University | 105 | 2021-08-18 | 2025-04-18 |
| Optimization of Initial Energy for Cardioversion of Atrial Fibrillation With Biphasic Shocks 100 joule as first biphasic shock energy, 120 joule as first biphasic shock energy - Atrial Fibrillation, Cardioversion | Not applicable | Unknown | Maria Vittoria Hospital | 154 | 2013-05-01 | 2013-07-30 |
Arrhythmias, Cardiac (3) · Cardiovascular Diseases (3) · Heart Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3)
Maria Vittoria Hospital (1) · Ottawa Heart Institute Research Corporation (1) · Yale University (1)
Canada (1) · Italy (1) · United States (1)
Joseph Ross, MD, MHS (1) · Massimo Imazio, MD (1) · Mehrdad Golian (1) · Peter Noseworthy, MD (1) · Sanket Dhruva, MD, MHS (1) · Sreekanth Vemulapalli, MD (1)